Yost: "Biology is just a better way to make stuff, right?" He says the kind of person who cares about what's in their products will want more sell-enginering. The same group that would be complaining about g m osor the ones going and ordering the impossible burgher are also likely to buy into this idea he says. Yost: We really have to educate the public on this; they literally don't understand the new nuclear power plants or exactly how safe they are.
First Jason explains how to deliver great investor updates & the benefits of doing them well (1:36). Then, Ginkgo Bioworks CEO Jason Kelly joins to discuss the expanding capabilities of synthetic biology (24:48), how Ginkgo is currently helping customers make products more effectively (35:58), the ethics & risks of editing DNA (51:53) & more!